Navigation Links
Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update
Date:11/7/2011

ncluding the adequacy of the Company's capital to support the Company's operations, the potential of the Company's ADASUVE NDA resubmission to adequately address the issues in the Complete Response Letter, the timing of the FDA's review of the NDA, the eventual prospects that ADASUVE will be approved for marketing in the U.S., and the timing and prospects for regulatory approval to market ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.ALEXZA PHARMACEUTICALS, INC.
(a development stage company)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Revenue

$
,259$
744$
3,776$
744Operating expenses:Research and development

8,0516,65420,97722,508General and administrative

3,1092,6108,66411,474Total operating expenses

11,1609,26429,64133,982Loss from operations

(9,901)(8,520)(25,865)(33,238)Loss on change in fair value of contingent consideration liability

(3,000)8,509(3,300)7,338Interest and other income/ (expense), net

13193028Interest expense

(529)(599)(1,703)(1,024)Net loss

'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
3. Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011
4. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
5. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
6. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
7. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
8. Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA
9. Alexza to Announce 2011 Second Quarter Financial Results on Monday, August 8, 2011
10. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
11. Alexza to Present at the MDB Bright Lights Conference 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 The March 3, 2015, order from ... must change their products, labels to clarify the drugs, intended ... and stroke is necessary to protect the public from injury ... partner at Simmons Hanly Conroy . The ... that the products – currently taken by millions of U.S. ...
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... , May 10 /PRNewswire-Asia/ -- On April ... cases with Beijing Un-Assegai Technical &,Trade Co. Ltd. (hereinafter referred ... China , as claimant and U.S. Abbott,Laboratories (Abbott U.S.; ... by the,China International Economic and Trade Arbitration Commission (CIETAC), which,has ...
... , Fla., May 10 Dr. Richard ... with newly diagnosed type 1 diabetes for Protege Encore, a ... of two Phase III studies testing the safety and efficacy ... as Protege, has completed enrollment of more than 530 subjects ...
Cached Medicine Technology:Assegai Wins Big Settlement Against ABBOTT's Subsidiary 2Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:3/5/2015)... COVINGTON, LOUISIANA (PRWEB) March 05, 2015 ... announce its continued support of the annual American Heart ... This year, Bret Kolman, Lakeview Regional Chief Executive Officer, ... take place on Saturday, March 21, 2015 at Fontainebleau ... event sponsorship, Lakeview Regional has 20 individual teams participating ...
(Date:3/5/2015)... New fiber fix heat wrap, a fiber glass adhesive launched ... kind product, manufactured to withstand the highest of temperatures. This ... in the market by customers who look to mold together ... cannot be done with the usual adhesives. , A spokesperson ... our new product Fiber Fix Heat Warp and already see ...
(Date:3/5/2015)... The cornerstone of the Vacuworx design ... smarter commercial lifting system and with the introduction of ... in more green construction projects . , Vacuworx ... System for lifting concrete road slabs and the Hydraulic ... projects. , The Octapad System was designed with ...
(Date:3/5/2015)... March 05, 2015 March is ... information campaign sponsored by the Academy of Nutrition ... a Healthy Lifestyle," which promotes the consumption of ... for achieving and maintaining a healthy weight, reducing ... , Whether a person is new to ...
(Date:3/5/2015)... Medical professionals suggest the physician shortage is no ... is worsening. The demand for doctors far exceeds the ... of the physician shortage, health care organizations and medical ... physicians and advanced practitioners throughout the U.S. through a ... Physician openings take an average of 204 days to ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Physician Shortage Crisis Worsening 2
... painful rashes. Prescription medications including steroid creams that ... ,When over five million Americans suffer from that ... frenzied response, especially when backed by some kind of ... even though experts are skeptical. ,"We can ...
... of anthropologists have embarked on a project to save Tibetan ... professor Gerald Roche, the volunteer-run Tibetan Endangered Music Project (TEMP) ... and return them back to the community. ,"The ... them to our communities. We want to record as many ...
... countries holding an international summit on bird flu in Aviemore ... birds are not an answer to the outbreaks of ... the Avian Flu Task Force under the UN international convention ... wild birds have been infected in some cases, the scientists ...
... to help people quit smoking? Get a national TV network ... of a new study that found calls to a national ... anchor Peter Jennings death from lung cancer. ,Its ... also have to advertise it, said Erik Augustson, a behavioral ...
... be negative, write Professor Desmond O'Neill and colleagues. Yet ... prudent driving behaviours. Furthermore, stopping driving can limit ... independent risk factor for entry into a nursing home. ... therefore try to balance mobility and safety in the ...
... Alteon Inc. announced today that it has dosed ... trial (Study 201) of ALT-2074, its lead glutathione peroxidase ... haptoglobin that renders them at high risk for cardiovascular ... designed to evaluate ALT-2074's ability to lower inflammatory cardiovascular ...
Cached Medicine News:Health News:Experts Critical of a New OTC Product to Treat Psoriasis 2Health News:Experts Critical of a New OTC Product to Treat Psoriasis 3Health News:Digital Music Project Aims to Save Tibetan Folk Songs from Extinction 2Health News:National TV Promotion Triples Calls to Smoking Cessation Hotline 2Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2
... enables highly sensitive time-resolved fluorescence detection ... fluorophores. These compounds are excited with ... fluorescence lifetimes (several hundred microseconds), large ... profiles at 620 nm. Therefore with ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... OPTIMA is a fully automated microplate ... different measurement principles:, , Fluorescence Polarization ... Fluorescence , High-Performance Luminescence (flash ... ,It is designed for the ...
... FLUOstar is a flexible multifunction plate reader ... one instrument: fluorescence intensity, time-resolved fluorescence, high-perfomance ... be equipped with injectors that deliver reagent ... fast kinetic cell assays can be performed ...
Medicine Products: